Industry News
New study reveals how to improve chemotherapy use in prostate cancer
Feb 19, 2015
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trialsProstate cancer is the second leading... Read More
Lack of RNA 'editing' leads to melanoma growth and metastasis
Feb 19, 2015
MD Anderson study finds regulated ADAR1 gene key contributorThe importance of RNA editing in melanoma has been demonstrated by scientists at The University of Texas MD Anderson Cancer Center. Read More
Bile duct cancer study may pave way for new treatments
Feb 19, 2015
Patients with bile duct cancer could be helped by a new class of experimental drug, a study has shown. Read More
Cancer experience presents time for lifestyle changes in both survivors and family members
Feb 19, 2015
After studying cancer survivors and their family caregivers, researchers at Case Western Reserve University conclude that the period between the final cancer treatment and first post-treatment... Read More
Mayo Clinic: Molecule that provides cellular energy found key to aggressive thyroid cancer
Feb 19, 2015
Cancer researchers at Mayo Clinic's campus in Jacksonville, Florida, have identified a molecule they say is important to survival of anaplastic thyroid carcinoma (ATC) -- a lethal tumor with no... Read More
New study reveals how to improve chemotherapy use in prostate cancer
Feb 19, 2015
Next generation chemotherapy for prostate cancer has unique properties that could make it more effective earlier in treatment if confirmed in clinical trialsProstate cancer is the second leading... Read More
Lack of RNA 'editing' leads to melanoma growth and metastasis
Feb 19, 2015
MD Anderson study finds regulated ADAR1 gene key contributorThe importance of RNA editing in melanoma has been demonstrated by scientists at The University of Texas MD Anderson Cancer Center. Read More
Anticoagulant fondaparinux associated with lower risk of bleeding and death following heart attack compared to heparin
Feb 18, 2015
Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months... Read More
Anticoagulant fondaparinux associated with lower risk of bleeding and death following heart attack compared to heparin
Feb 18, 2015
Patients who experienced a certain type of heart attack who received the anticoagulant fondaparinux had a lower risk of major bleeding events and death both in the hospital and after six months... Read More
New therapeutic strategy discovered for ovarian cancer
Feb 18, 2015
The findings could revolutionize treatment for patients with ovarian clear cell carcinoma, a very difficult to treat subtype of ovarian cancerOvarian cancer is the deadliest of all cancers... Read More
Previous Page Next Page